On June 30, I sold all of my Vanguard Short-Term Corporate Bond Index Fund Admiral Shares, which were valued at $80,000. I ...
This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern ...
Dear Quentin, I am a 63-year-old semiretired physician. Years ago I said that I would gladly opt out of Social Security if, ...
The “Mag Seven” stocks have become the “Bag Seven” — or worse. That was fun while it lasted.
Five days before the Federal Reserve’s interest-rate committee meets, there is a lot of uncertainty about what the central ...
NextEra Energy recorded a big jump in profit for the second quarter from climbing revenue and a decline in costs. The clean-energy company posted a profit of $3.14 billion, or $1.50 a share, up from ...
Bluerock Acquisition Corp. II has filed for an initial public offering. The special-purpose acquisition company said it will sell 15 million units at $10 apiece, according to a filing with the ...
Shares of Outlook Therapeutics posted wide swings as the Food and Drug Administration approved the company's Lytenava for treatment of neovascular age-related macular degeneration.
The stock's fall snapped a five-day winning streak.
U.S. stocks steadied Friday and oil pulled back from the prior session's $100-a-barrel peak on reports that Pakistan and Iran were exploring a path toward new talks with the U.S., offering investors a ...
The USDA on Friday published its biannual Cattle Inventories Report, as well as its monthly Cattle on Feed Report, which both showed more cattle in the U.S. The amount of cattle o ...
Oil prices aren’t yet near the level economists had said would put the global economy in jeopardy of a recession.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results